Enliven Therapeutics (ELVN) Earnings Date & Reports
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ELVN is expected to report earnings to rise 42.38% to -45 cents per share on March 12
Q4'25
Est.
$-0.46
Q3'25
Beat
by $0.18
Q2'25
Beat
by $0.06
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.06
The last earnings report on November 12 showed earnings per share of -31 cents, beating the estimate of -50 cents. With 180.85K shares outstanding, the current market capitalization sits at 1.20B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELVN showed earnings on November 12, 2025. You can read more about the earnings report here.